The Centers for Disease Control and Prevention (CDC) recommended preexposure prophylaxis (PrEP) to injection drug users who are at high risk of HIV infection, following the positive results of the Bangkok Tenovir Study, published online June 12 in the Lancet.
Former Health and Human Services Secretary Tommy Thompson is leading a group that wants greater FDA oversight of compounding pharmacies, including restrictions on the drugs they can produce.
FDA has approved the use of Plan B One-Step (levonorgestrel) as a nonprescription product for all women of child-bearing potential. This action complies with the April 5, 2013 order of the United States District Court in New York to make levonorgestrel-containing emergency contraceptives available as an over-the-counter (OTC) product without age or point-of-sale restrictions.
FDA approved a test that identifies the genotype of hepatitis C virus (HCV) that a patient is carrying.
APhA DrugInfoLine, an online publication that provides drug-news updates to members of the American Pharmacists Association (APhA), has named Kristin W. Weitzel editor-in-chief.
The effectiveness of new drugs compared with that of older drugs has fallen since the 1970s, according to a new study in Health Affairs.
Janet Silvester, former president and board member of the American Society of Health-System Pharmacists (ASHP), will rejoin that organization as its vice president of accreditation services.
FDA approved the expanded use of denosumab (Xgeva, Amgen) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually non-cancerous tumor.
FDA is investigating 2 unexplained deaths in patients who received an intramuscular injection of the antipsychotic drug Zyprexa Relprevv (olanzapine pamoate), according to an FDA Drug Safety Communication.
The U.S. Supreme Court today ruled that pay-for-delay agreements between brand name drug companies and generic manufacturers are subject to antitrust scrutiny.
The Center for Medicare and Medicaid Services (CMS) is seeking comments on its proposed rule on the Health Insurance Marketplace set forth by the Affordable Care Act.
More face-to-face interaction between pharmacists and patients would reduce chronic diseases, cut healthcare costs, and lessen the misuse of medications, according to a May 21 white paper by RxAlly.
How to handle the folks who think that none of the rules apply to them
Two new analyses result in conflicting findings
Even with inadequate help and pressure from above, the pharmacist must always put the patient first
Doctors would have to prescribe antibiotics to 12,000 patients diagnosed with common colds to prevent one hospital admission for pneumonia, study shows
Remember that Nike ad? Just do it!
Advocacy and education will change attitudes
Patient-centered outcomes research makes pharmacists even more important members of the healthcare team
As you fill the Rx for that "little blue pill," use the opportunity to tell patients that ED can be a precursor of heart disease
Six steps compounding pharmacies can take to create and maintain a culture of quality assurance
"Compounders" and "compounding manufacturers" defined
Approval requires canagliflozin manufacturer to complete five post-marketing studies
Through patient education and screening processes, pharmacists can identify and support underserved patients with mental illness
Drug Topics readers weigh in
FDA asks stakeholders to weigh in on solutions
How can health systems simultaneously improve population health and patient satisfaction, yet reduce per capita costs? A Walgreens model points the way.
New Rx, Generics, and OTC
For the third consecutive year, Walgreens is partnering with Greater Than AIDS and local health departments across the country to provide free HIV testing between June 27 and June 29.